Placeholder Banner

2015 BIO CEO & Investor Conference™ to Feature Dynamic List of Company Presentations

November 12, 2014
Past and future attendees of the annual BIO CEO & Investor Conference have high expectations for the caliber of company’s chosen to present at the event. Presenting companies are hand selected for the event and consist of a selection of mid to large cap established public companies from around the globe who typically have a clinical stage program centered on therapeutics, molecular diagnostics, or a platform technology, as well as an upcoming clinical, regulatory or corporate catalyst.

A special track of presentations will once again feature private companies. Presentations in this track will be 13 minutes in length, and will be reserved specifically for established private companies (past Series B round and >$25M raised to date).

To date, the 2015 BIO CEO & Investor Conference, February 9-10 at the Waldorf Astoria, New York City, currently has 132 company presentations confirmed with room for only a handful more. To learn more about presenting, please visit here.

The Buzz of BIO contest, sponsored by BioCentury and Tiberend Strategic Advisors, is being launched for the first time as part of the BIO CEO & Investor Conference, and offers another opportunity for companies to stand out at the event. The contest recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. Ten biotechs will be nominated in each of two categories – Most Distinguished Public Company and Most Promising Private Company.

During the contest, industry peers will be voting for companies they want to see and hear from at the BIO CEO & Investor Conference. One winner from each of the two categories will receive complimentary conference registration, a Company Presentation and promotion to industry leaders including a spotlight in BioCentury Extra.

Nominations open next Monday, November 17th and public voting opens Monday, December 1st. To learn more, visit here.

This year’s BIO CEO & Investor Conference program will include plenary sessions, business roundtables, therapeutic workshops and fireside chats featuring respected industry veterans discussing the latest trends in biotech. To learn more about the event, including registration, program, company presentation and partnering information, please visit here.

Registration for credentialed members of the media is now open.